RxDoctor Payments Data

Jerry Wolinsky

Neurology · Houston, TXNPI 1578599007

Payments from drug & device makers

$165,360in general payments, 2019–2025

Across 138 payments — averaging $1198.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • F. Hoffmann-la Roche AG$54K
  • Novartis Pharma AG$41K
  • Sanofi-aventis U.S. LLC$19K
  • Genentech, Inc.$16K
  • EMD Serono, Inc.$13K
  • Greenwich Biosciences, Inc.$7K
  • plus $15K from 7 others
$103,950in research payments, 2019–2025

Across 71 payments — averaging $1464.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$82K
  • Novartis Pharma AG$16K
  • Genentech, Inc.$3K
  • EMD Serono, Inc.$2K
  • Sanofi-aventis U.S. LLC$1K
  • Sanofi$449

What the payments were for

  • Consulting fees$79,74548%
  • Speaking & faculty fees$43,66726%
  • Travel & lodging$40,54125%
  • Food & beverage$1,4071%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$165,360 in reported general payments places this provider in the 85th percentile of 1,246 neurology providers in Texas.

See all neurology providers in Texas

Other neurology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →